metsera glp-1 Pfizer Acquires for $4.9 B, Boosts Obesity Pipeline | Jayaprakash Kolla posted on the topic Weight-loss newbie Metsera says once-monthly

GLP-1 and Dual GIP/GLP-1 Agonists for Obesity: Are They Right for You

We reviewed the current state of research on the clinical application of ICH, highlighting their limitations, and describe the preclinical evidence supporting the use of HPL in the treatment of ICH

Figure 1 Subject Selection, Clinical Encounters, and Blood Collection Patients were recruited from the on-campus clinic, the Patient Care Center (PCC) of Western University of Health Sciences, from October 2018 until the target sample size was reached for both the experimental and placebo-controlled arm

The remaining 309 articles underwent full-text assessment